Review Article

Models for the Study of Whole-Body Glucose Kinetics: A Mathematical Synthesis

Table 3

Example literature values from insulin-dependent minimal model for describing glucose kinetics.

ReferencePopulation (species); per group; body weight (kg)Experimental groups/conditionsTestIsotopeGE (min−1)IS ( U−1 min−1 mL × 10−4)*
CTCT

[19]Canine (Mongrel); 5 (C); 8 (T); ~25Low (C) versus high (T) dose IVGTT13.9 ± 5.377.00 ± 0.59
[20]Canine (Beagle); 6; 11 ± 2Cold (no isotope) (C) versus labelled (T)IVGTT2-3H0.042 ± 0.0090.009 ± 0.0014.52 ± 1.396.41 ± 0.91
[24]Canine (Mixed); 8;
27.2 ± 1.1
Healthy (C) versus Acepromazine (T)IVGTT0.04 ± 0.01 0.03 ± 0.006.6 ± 1.0 7.7 ± 2.3
[25]Canine (Mixed); 6;
22 ± 4.4 (C); 45 ± 18.4 (T)
Healthy (C) versus obese (T)IVGTT3.0 ± 0.8 6.5 ± 1.5
[26]Canine (Mongrel); 9;
35.9 ± 1.4 (C); 42.4 ± 2.1 (T)
Chow diet (C) versus high fat diet (T)tmIVGTT0.031 ± 0.40 0.020 ± 0.2613.6 ± 1.74 5.87 ± 1.21
[27]Canine (Mongrel); 6;
28.2 ± 1.7
Chow diet (C) versus high fat diet (T)imIVGTT0.041 ± 0.0040.051 ± 0.0063.98 ± 0.541.40 ± 0.55
[28]Canine (Mixed); 8, ~13Healthy (C) versus hypothyroid (T)imIVGTT0.043 ± 0.0090.043 ± 0.01123.6 ± 5.3 4.9 ± 1.2
[23]Feline (Domestic Shorthair); 10;
3.74 ± 0.36 (C); 6.6 ± 0.79 (T)
Healthy (C) versus obese (T)EHC3-3H0.0160.0132.58 ×
IVGTT3-3H6.27 ×

C, control group; T, treatment group, GE, glucose effectiveness; IS, insulin sensitivity; IVGTT, intravenous glucose tolerance test; tmIVGTT, tolbutamide modified intravenous glucose tolerance test; imIVGTT, insulin modified glucose tolerance test; EHC, euglycemic hyperinsulinemic clamp; refers to per unit of concentration; units of min−1 pmol−1 L; data are presented as mean ± SE.